These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20711164)

  • 21. Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?
    Martenot A; Devoti JF; Pons M; Meyer C; Brumpt E; Louvrier A; Bertin E
    J Stomatol Oral Maxillofac Surg; 2024 Oct; 125(5):101715. PubMed ID: 38013116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatosensory input and oromandibular dystonia.
    Møller E; Bakke M; Dalager T; Werdelin LM; Lonsdale MN; Højgaard L; Friberg L
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1141-3. PubMed ID: 23036658
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
    Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
    Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Office-based Electromyography-guided Botulinum Toxin Injection to the Cricopharyngeus Muscle: Optimal Patient Selection and Technique.
    Kim MS; Kim GW; Rho YS; Kwon KH; Chung EJ
    Ann Otol Rhinol Laryngol; 2017 May; 126(5):349-356. PubMed ID: 28397562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
    Singer C; Papapetropoulos S; Vela L
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
    [No Abstract]   [Full Text] [Related]  

  • 27. Lateral pterygoid muscle ultrasound-guided injection: A technical note.
    Rodríguez-Gimillo P; Valverde-Navarro A; Margaix-Muñoz M; Poveda-Roda R; Delgado-Navarro C; Puig-Bernabeu J
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101547. PubMed ID: 37394100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective botulinum toxin injection guide for treatment of cervical dystonia.
    Yi KH; Choi YJ; Cong L; Lee KL; Hu KS; Kim HJ
    Clin Anat; 2020 Mar; 33(2):192-198. PubMed ID: 31301235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of focal dystonia of the extensor hallucis longus muscle with botulinum toxin injection: a case report.
    Sherman AL; Willick SP; Cardenas DD
    Arch Phys Med Rehabil; 1998 Oct; 79(10):1303-5. PubMed ID: 9779689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum toxin injections under electromyographic guidance].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():85-93. PubMed ID: 9608557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR-guided navigation for botulinum toxin injection in the lateral pterygoid muscle. First results in the treatment of temporomandibular joint disorders.
    Pons M; Meyer C; Euvrard E; Weber E; Sigaux N; Louvrier A
    J Stomatol Oral Maxillofac Surg; 2019 Jun; 120(3):188-195. PubMed ID: 30453102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oromandibular Dystonia: A Case Report of the Lateral Pterygoid Muscle Involvement and Treatment with Botulinum Toxin A.
    Alexoudi A; Dalivigka Z; Siatouni A; Verentzioti A; Gatzonis S
    Clin Pract; 2016 Aug; 6(3):862. PubMed ID: 27777710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.